Hepatitis C drugs on every 2026 Puerto Rico Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 3 stand-alone Part D plans in Puerto Rico cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
| Drug | HealthSpring Extra Rx$50.00/moS5617-385 | HealthSpring Assurance Rx$65.70/moS5617-348 | AARP Medicare Rx Preferred from UHC$145.10/moS5820-037 |
|---|---|---|---|
| Epclusasofosbuvir and velpatasvir | Tier 5PA25%QL 28/28d | Tier 5PA25%QL 28/28d | Not covered |
| sofosbuvir-velpatasvirgeneric Epclusa | Not covered | Not covered | Tier 5PA25%QL 28/28d |
| Mavyretglecaprevir and pibrentasvir | Not covered | Not covered | Tier 5PA25%QL 140/28d |
| Harvoniledipasvir and sofosbuvir | Tier 5PA25%QL 28/28d | Tier 5PA25%QL 28/28d | Not covered |
| ledipasvir-sofosbuvirgeneric Harvoni | Not covered | Not covered | Not covered |
| Vosevisofosbuvir | Tier 5PA25%QL 28/28d | Tier 5PA25%QL 28/28d | Tier 5PA25%QL 28/28d |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.